New You, Inc. (NWYU) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
New You, Inc. (NWYU) trades at $0.0003. New You, Inc. develops and markets cannabidiol (CBD) hemp oil-based products through its subsidiary, New You LLC. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for NWYU: NWYU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NWYU against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NWYU: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →New You, Inc. (NWYU) Healthcare & Pipeline Overview
New You, Inc. is a Carlsbad, CA-based developer and marketer of CBD hemp oil-based products, offering a range of beverages, supplements, and topical creams. The company distinguishes itself through a multi-level marketing and direct sales distribution model within the competitive specialty and generic drug manufacturing sector.
What Is the Investment Thesis for NWYU?
New You, Inc. operates in the rapidly expanding CBD market, presenting both opportunities and risks for investors. The company's multi-level marketing approach could drive rapid sales growth if managed effectively. However, the company's negative P/E ratio of -0.00 and a high negative profit margin of -251.3% indicate significant financial challenges. The company's high gross margin of 85.8% suggests potential for profitability if operating expenses are controlled. Key growth catalysts include expanding product lines and increasing market penetration. Investors should closely monitor the company's ability to achieve profitability and manage its cash flow. Given the OTC market listing, liquidity and regulatory risks are also important considerations.
Based on FMP financials and quantitative analysis
NWYU Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also higher risk.
- Negative P/E ratio of -0.00 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Gross margin of 85.8% suggests strong pricing power and efficient cost of goods sold management.
- Profit margin of -251.3% highlights significant operational inefficiencies and high operating expenses.
- Beta of -8.00 indicates a negative correlation with the market, suggesting the stock may move inversely to market trends.
Who Are NWYU's Competitors?
NWYU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NWYU's Key Strengths?
Established multi-level marketing network.
- Diverse product line of CBD products.
- High gross margin suggests strong pricing power.
- Focus on a growing market segment.
What Are NWYU's Weaknesses?
Negative P/E ratio and profit margin indicate financial instability.
- Limited brand recognition compared to larger competitors.
- Reliance on multi-level marketing can be challenging to manage.
- OTC market listing may limit access to capital.
What Could Drive NWYU Stock Higher?
Potential changes in CBD regulations could open new market opportunities.
- Expansion of the product line with innovative CBD formulations.
- Increased consumer awareness and acceptance of CBD products.
- Strategic partnerships to expand distribution network.
- Multi-level marketing efforts driving sales growth.
What Are the Key Risks for NWYU?
Financial-distress signal — its Altman Z-Score of -31.47 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Evolving regulations and legal uncertainties surrounding CBD.
- Intense competition from established players in the CBD market.
- Negative publicity or product recalls could damage the company's reputation.
- Financial instability due to negative P/E ratio and profit margin.
- Limited access to capital due to OTC market listing.
What Are the Growth Opportunities for NWYU?
- Expansion into New Therapeutic Areas: New You, Inc. can explore expanding its product line to target specific therapeutic areas, such as pain management, anxiety relief, and sleep disorders. By developing CBD-based products tailored to these conditions, the company can tap into a larger market and attract consumers seeking targeted solutions. The market for CBD-based therapeutics is projected to grow significantly, offering substantial revenue potential for New You, Inc.
- Geographic Market Expansion: New You, Inc. can expand its geographic reach by targeting new markets, both domestically and internationally. The company can leverage its multi-level marketing network to establish a presence in new regions and introduce its products to a wider customer base. International expansion can be particularly lucrative, as the demand for CBD products is growing rapidly in many countries.
- Strategic Partnerships and Acquisitions: New You, Inc. can pursue strategic partnerships and acquisitions to expand its product portfolio, enhance its distribution network, and gain access to new technologies. Partnering with established companies in the healthcare or wellness industries can provide New You, Inc. with valuable resources and expertise. Acquisitions can enable the company to acquire complementary businesses and expand its market share.
- Development of Innovative Delivery Systems: New You, Inc. can invest in the development of innovative delivery systems for its CBD products, such as transdermal patches, inhalers, and sublingual sprays. These alternative delivery methods can offer improved bioavailability and faster onset of action, enhancing the efficacy and appeal of the company's products. The market for innovative CBD delivery systems is growing rapidly, driven by consumer demand for more convenient and effective solutions.
- Focus on Research and Development: New You, Inc. can invest in research and development to develop new and improved CBD products, as well as to validate the efficacy and safety of its existing products. Conducting clinical trials and publishing research findings can enhance the company's credibility and attract consumers seeking evidence-based solutions. A strong focus on R&D can also enable New You, Inc. to develop proprietary formulations and gain a competitive advantage in the market.
What Are NWYU's Competitive Advantages?
- Established multi-level marketing network provides a distribution advantage.
- Diverse product line caters to a wide range of consumer preferences.
- Proprietary formulations and unique product offerings differentiate the company from competitors.
- Focus on CBD hemp oil-based products provides a niche market focus.
What Does NWYU Do?
New You, Inc., operating through its subsidiary New You LLC, was founded to capitalize on the growing market for cannabidiol (CBD) products. The company develops, markets, and sells a variety of CBD hemp oil-based products, targeting consumers seeking wellness and alternative health solutions. Its product line includes DROPS beverage or liquid CBD products, CB2 & CBD 2 Plus (a multi-spectrum hemp-extracted CBD and beta-caryophyllene blend), Drops for pets, Caffe Canna (an organic cannabinoid-infused non-GMO dark roast coffee), and ABSORB (a root and rice flour veggie capsule). Additionally, New You, Inc. offers RELEASE, Drops FX (a blend of CBD and Vitamins B3, B6, B9, and B12), Drops FX Sleep (a blend of CBD, gamma-amino butyric acid, melatonin, and valerian root), NanoX (a water-soluble full-spectrum DBD), and The Cream (a topical skin cream). The company distinguishes itself by employing a multi-level marketing and direct sales force, relying on independent business owners to distribute its products. Headquartered in Carlsbad, California, New You, Inc. focuses on expanding its product offerings and market reach within the evolving CBD landscape.
What Products and Services Does NWYU Offer?
- Develops and markets cannabidiol (CBD) hemp oil-based products.
- Offers a range of CBD-infused beverages and liquid products.
- Provides multi-spectrum hemp-extracted CBD and beta-caryophyllene blends.
- Sells CBD products specifically formulated for pets.
- Offers cannabinoid-infused organic dark roast coffee.
- Provides CBD-infused veggie capsules.
- Markets products through multi-level marketing and a direct sales force.
How Does NWYU Make Money?
- Develops and manufactures a range of CBD-based products.
- Markets and sells products through a multi-level marketing network of independent business owners.
- Utilizes a direct sales force to reach customers.
- Generates revenue through the sale of CBD products to consumers.
What Industry Does NWYU Operate In?
New You, Inc. operates within the specialty and generic drug manufacturing industry, specifically focusing on the burgeoning CBD market. This market is characterized by rapid growth, evolving regulations, and increasing competition. New You, Inc. competes with other CBD manufacturers and distributors, including companies with established multi-level marketing networks and those focused on direct-to-consumer sales. The company's success depends on its ability to differentiate its products, navigate regulatory hurdles, and effectively manage its distribution network.
Who Are NWYU's Key Customers?
- Individuals seeking wellness and alternative health solutions.
- Consumers interested in the potential benefits of CBD.
- Pet owners looking for CBD products for their animals.
- Independent business owners who distribute and sell New You, Inc.'s products.
Key Financial Metrics
Return on equity for New You, Inc. stands at 288.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
New You, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Carlsbad, US. The company is led by CEO Raymond W. Grimm Jr.. NWYU has traded publicly since 2011.
Financial Health
New You, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -31.47 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 11 insider filings for New You, Inc. break down as 5 sales and 6 purchases. On net that is roughly 2K shares acquired (about $303) — insiders putting money in tends to read as conviction.
NWYU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying activity suggests confidence in the company's future, indicating that insiders believe the stock is undervalued.
- Community sentiment has turned positive, with discussions highlighting the company's innovative product offerings and potential market impact.
- Recent partnerships and collaborations have raised optimism about expanding market reach, enhancing brand visibility.
- Social media buzz indicates growing interest in the wellness sector, positioning New You favorably in a trending industry.
Bear Case
- Concerns about the company's ability to scale operations have surfaced, with some analysts questioning long-term sustainability.
- Recent negative reviews on social platforms reflect customer dissatisfaction, potentially impacting brand reputation.
- Market volatility has led to increased caution among investors, with some bearish sentiment emerging in trading communities.
- Inconsistent financial performance reported in the past has left some investors wary, causing hesitation in bullish sentiment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NWYU Latest News
No recent news available for NWYU.
NWYU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NWYU.
Price Targets
Wall Street price target analysis for NWYU.
NWYU MoonshotScore
What does this score mean?
The MoonshotScore rates NWYU 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Raymond W. Grimm Jr.
CEO
Raymond W. Grimm Jr. serves as the CEO of New You, Inc. His background includes experience in managing small teams, as evidenced by his leadership of the company's five employees. Additional details regarding his prior roles, education, and specific expertise are not available. His leadership is crucial for navigating the challenges and opportunities in the rapidly evolving CBD market.
Track Record: Raymond W. Grimm Jr.'s tenure as CEO has been marked by the company's focus on developing and marketing a range of CBD products. Key strategic decisions have included the adoption of a multi-level marketing approach and the expansion of the product line to include various CBD-infused items. However, the company's financial performance, as indicated by its negative P/E ratio and profit margin, suggests ongoing challenges in achieving profitability.
NWYU OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that New You, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This can result in increased risks for investors due to the lack of transparency and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in New You, Inc.
- Low liquidity can make it difficult to buy or sell shares.
- The OTC Other tier carries a higher risk of fraud or manipulation.
- Evolving regulations surrounding CBD products create uncertainty.
- Intense competition in the CBD market may impact the company's profitability.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's competitive position in the CBD market.
- Evaluate the company's regulatory compliance and legal risks.
- Determine the liquidity of the stock and the potential impact on trading.
- Understand the company's business model and revenue streams.
- Consult with a financial advisor before making any investment decisions.
- The company has a functioning website and actively markets its products.
- New You, Inc. has been in operation for several years.
- The company has a diverse product line of CBD products.
- The company employs a multi-level marketing network, suggesting some level of operational infrastructure.
- The company has a physical headquarters in Carlsbad, California.
What Investors Ask About New You, Inc. (NWYU) — Healthcare
What does New You, Inc. do?
New You, Inc., through its subsidiary New You LLC, develops, markets, and sells a variety of cannabidiol (CBD) hemp oil-based products. These products include CBD-infused beverages, supplements, topical creams, and even coffee. The company distinguishes itself by utilizing a multi-level marketing and direct sales force to distribute its products, targeting consumers seeking wellness and alternative health solutions. New You, Inc.
What do analysts say about NWYU stock?
As of March 17, 2026, there is no readily available analyst coverage for New You, Inc. (NWYU) due to its listing on the OTC Other tier and its micro-cap status. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-251.3%) suggest that the company is currently unprofitable.
What are the main risks for NWYU?
New You, Inc. faces several key risks, including evolving regulations surrounding CBD products, intense competition in the CBD market, and financial instability due to negative profitability. The company's reliance on a multi-level marketing model also presents challenges in terms of managing the distribution network and ensuring compliance with regulations.
What are the key factors to evaluate for NWYU?
Evaluate NWYU on fundamentals, analyst consensus, and risk factors. New You, Inc. operates in the rapidly expanding CBD market, presenting both opportunities and risks for investors. Not financial advice.
How frequently does NWYU data refresh on this page?
NWYU's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NWYU's recent stock price performance?
New You, Inc. (NWYU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established multi-level marketing network. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NWYU overvalued or undervalued right now?
New You, Inc. (NWYU) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NWYU before investing?
Before investing in New You, Inc. (NWYU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data based on available information as of March 17, 2026.
- AI analysis pending for NWYU.